Basal and inducible Osterix expression reflect equine mesenchymal progenitor cell osteogenic capacity.
Authors: Andrietti Antonella Liza Pantaleoni, Durgam Sushmitha S, Naumann Brittany, Stewart Matthew
Journal: Frontiers in veterinary science
Summary
# Editorial Summary: Osterix Expression as a Marker of Osteogenic Potential in Equine Mesenchymal Progenitor Cells Mesenchymal progenitor cells derived from different equine tissues possess varying capacities for bone formation, yet clinicians lack reliable markers to predict osteogenic differentiation before committing to therapeutic use. Andrietti and colleagues investigated whether baseline and induced expression of key transcription factors—particularly Osterix and Runx2—could serve as indicators of osteogenic potential in cells harvested from bone marrow, synovium, and adipose tissue. The research demonstrated that Osterix expression, both at rest and following osteogenic induction, correlates directly with each cell source's capacity to differentiate along the bone-forming pathway, offering a potentially valuable screening tool for selecting the most appropriate cell populations for orthopaedic applications. This finding matters considerably for regenerative medicine practitioners, as it suggests that simple gene expression profiling could optimise cell selection before implantation, potentially improving clinical outcomes in fracture repair, bony lesion healing, and degenerative joint disease—without requiring lengthy in vitro differentiation protocols to assess suitability. For farriers and therapists collaborating with veterinary teams on performance horses with skeletal injuries, understanding these cellular markers may help facilitate more informed discussions about which regenerative approaches offer the strongest biological foundation for the specific tissue damage being treated.
Read the full abstract on PubMed
Practical Takeaways
- •Cell source selection matters—bone marrow and synovium-derived cells may have superior osteogenic potential compared to adipose-derived cells for bone healing applications
- •Osterix expression could serve as a practical screening marker to identify and select mesenchymal progenitor cells with the highest bone-healing capacity before clinical use
- •Understanding intrinsic osteogenic capacity of different cell sources supports evidence-based decisions when considering regenerative medicine options for equine orthopedic injuries
Key Findings
- •Basal and inducible Osterix expression correlates with osteogenic capacity across equine mesenchymal progenitor cell sources
- •Osteogenic differentiation capacity varies between bone marrow-, synovium-, and adipose-derived equine cells
- •Runx2 and Osterix transcription factor expression reflects the tri-lineage differentiation potential of equine mesenchymal stem cells